{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T04:33:01Z","timestamp":1772253181311,"version":"3.50.1"},"reference-count":57,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2004,8,1]],"date-time":"2004-08-01T00:00:00Z","timestamp":1091318400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Otolaryngologic Clinics of North America"],"published-print":{"date-parts":[[2004,8]]},"DOI":"10.1016\/j.otc.2004.02.004","type":"journal-article","created":{"date-parts":[[2005,4,18]],"date-time":"2005-04-18T14:53:11Z","timestamp":1113835991000},"page":"701-713","source":"Crossref","is-referenced-by-count":46,"title":["Primary, secondary, and tertiary hyperparathyroidism"],"prefix":"10.1016","volume":"37","author":[{"given":"Rehan","family":"Ahmad","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James M","family":"Hammond","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.otc.2004.02.004_BIB1","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1056\/NEJM196605262742105","article-title":"The study of hyperparathyroidism at the Massachusetts General Hospital","volume":"274","author":"Cope","year":"1966","journal-title":"N Engl J Med"},{"key":"10.1016\/j.otc.2004.02.004_BIB2","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1056\/NEJM198001243020402","article-title":"Primary hyperparathyroidism. Incidence, morbidity, and potential economic impact in a community","volume":"302","author":"Heath","year":"1980","journal-title":"N Engl J Med"},{"key":"10.1016\/j.otc.2004.02.004_BIB3","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1016\/S0140-6736(80)91783-3","article-title":"Primary hyperparathyroidism: changes in the pattern of clinical presentation","volume":"1","author":"Mundy","year":"1980","journal-title":"Lancet"},{"key":"10.1016\/j.otc.2004.02.004_BIB4","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1136\/bmj.3.5615.395","article-title":"Tertiary hyperparathyroidism","volume":"2","author":"Davies","year":"1968","journal-title":"BMJ"},{"issue":"Suppl 2","key":"10.1016\/j.otc.2004.02.004_BIB5","first-page":"N12","article-title":"The epidemiology of primary hyperparathyroidism in North America","volume":"17","author":"Melton","year":"2002","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.otc.2004.02.004_BIB6","doi-asserted-by":"crossref","first-page":"433","DOI":"10.7326\/0003-4819-126-6-199703150-00003","article-title":"The rise and fall of primary hyperparathyroidism: a population-based study in Rochester, Minnesota, 1965\u20131992","volume":"126","author":"Wermers","year":"1997","journal-title":"Ann Intern Med"},{"issue":"Suppl 2","key":"10.1016\/j.otc.2004.02.004_BIB7","first-page":"N18","article-title":"Epidemiology of primary hyperparathyroidism in Europe","volume":"17","author":"Adami","year":"2002","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.otc.2004.02.004_BIB8","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1001\/archsurg.1992.01420070095018","article-title":"Continuing evolution in the operative management of primary hyperparathyroidism","volume":"127","author":"Salti","year":"1992","journal-title":"Arch Surg"},{"key":"10.1016\/j.otc.2004.02.004_BIB9","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1002\/bjs.1800820723","article-title":"Clinical and surgical aspects of double adenoma in patients with primary hyperparathyroidism","volume":"82","author":"Bartsch","year":"1995","journal-title":"Br J Surg"},{"key":"10.1016\/j.otc.2004.02.004_BIB10","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1097\/00005792-199207000-00002","article-title":"Parathyroid carcinoma: clinical and pathologic features in 43 patients","volume":"71","author":"Wynne","year":"1992","journal-title":"Medicine (Baltimore)"},{"issue":"Suppl 2","key":"10.1016\/j.otc.2004.02.004_BIB11","first-page":"N24","article-title":"The pathophysiology of primary hyperparathyroidism","volume":"17","author":"Brown","year":"2002","journal-title":"J Bone Miner Res"},{"issue":"Suppl 2","key":"10.1016\/j.otc.2004.02.004_BIB12","first-page":"N30","article-title":"Molecular pathogenesis of primary hyperparathyroidism","volume":"17","author":"Arnold","year":"2002","journal-title":"J Bone Miner Res"},{"issue":"Suppl 2","key":"10.1016\/j.otc.2004.02.004_BIB13","first-page":"N37","article-title":"Hyperparathyroidism in hereditary syndromes: special expressions and special managements","volume":"17","author":"Marx","year":"2002","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.otc.2004.02.004_BIB14","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.1210\/jc.81.6.2036","article-title":"Evaluation and management of primary hyperparathyroidism","volume":"81","author":"Silverberg","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.otc.2004.02.004_BIB15","series-title":"Williams textbook of endocrinology","author":"Williams","year":"2003"},{"key":"10.1016\/j.otc.2004.02.004_BIB16","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1359\/jbmr.1997.12.5.856","article-title":"Primary hyperparathyroidism: still evolving?","volume":"12","author":"Silverberg","year":"1997","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.otc.2004.02.004_BIB17","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1016\/S0039-6060(98)70038-8","article-title":"Case-control study on symptoms and signs of \u201casymptomatic\u201d primary hyperparathyroidism","volume":"124","author":"Lundgren","year":"1998","journal-title":"Surgery"},{"key":"10.1016\/j.otc.2004.02.004_BIB18","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1097\/00000658-199509000-00017","article-title":"Clinical manifestations of primary hyperparathyroidism before and after parathyroidectomy. A case-control study","volume":"222","author":"Chan","year":"1995","journal-title":"Ann Surg"},{"key":"10.1016\/j.otc.2004.02.004_BIB19","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1136\/bmj.317.7162.848","article-title":"Population based case-control study of sick leave in postmenopausal women before diagnosis of hyperparathyroidism","volume":"317","author":"Lundgren","year":"1998","journal-title":"BMJ"},{"key":"10.1016\/j.otc.2004.02.004_BIB20","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1136\/pgmj.65.767.628","article-title":"Psychiatric morbidity in primary hyperparathyroidism","volume":"65","author":"McAllion","year":"1989","journal-title":"Postgrad Med J"},{"key":"10.1016\/j.otc.2004.02.004_BIB21","doi-asserted-by":"crossref","first-page":"77","DOI":"10.3109\/03009738609178493","article-title":"Psychiatric symptomatology in patients with primary hyperparathyroidism","volume":"91","author":"Joborn","year":"1986","journal-title":"Ups J Med Sci"},{"key":"10.1016\/j.otc.2004.02.004_BIB22","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/S0889-8529(05)70145-6","article-title":"Natural history of primary hyperparathyroidism","volume":"29","author":"Silverberg","year":"2000","journal-title":"Endocrinol Metab Clin N Am"},{"issue":"Suppl 2","key":"10.1016\/j.otc.2004.02.004_BIB23","first-page":"N117","article-title":"Non-classical target organs in primary hyperparathyroidism","volume":"17","author":"Silverberg","year":"2002","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.otc.2004.02.004_BIB24","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1056\/NEJM199910213411701","article-title":"A 10-year prospective study of primary hyperparathyroidism with or without parathyroid surgery","volume":"341","author":"Silverberg","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.otc.2004.02.004_BIB25","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/0002-9343(90)90346-F","article-title":"Nephrolithiasis and bone involvement in primary hyperparathyroidism","volume":"89","author":"Silverberg","year":"1990","journal-title":"Am J Med"},{"issue":"Suppl 2","key":"10.1016\/j.otc.2004.02.004_BIB26","first-page":"N87","article-title":"Primary hyperparathyroidism and the kidney: biochemical and clinical spectrum","volume":"17","author":"Peacock","year":"2002","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.otc.2004.02.004_BIB27","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1359\/jbmr.1999.14.10.1700","article-title":"Primary hyperparathyroidism and the risk of fracture: a population-based study","volume":"14","author":"Khosla","year":"1999","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.otc.2004.02.004_BIB28","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/BF00316875","article-title":"Bone strength: the bottom line","volume":"51","author":"Einhorn","year":"1992","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.otc.2004.02.004_BIB29","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1002\/jbmr.5650040302","article-title":"Skeletal disease in primary hyperparathyroidism","volume":"4","author":"Silverberg","year":"1989","journal-title":"J Bone Miner Res"},{"issue":"Suppl 2","key":"10.1016\/j.otc.2004.02.004_BIB30","first-page":"N98","article-title":"Bone densitometry in asymptomatic primary hyperparathyroidism","volume":"17","author":"Miller","year":"2002","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.otc.2004.02.004_BIB31","doi-asserted-by":"crossref","first-page":"4007","DOI":"10.1210\/jc.81.11.4007","article-title":"Vertebral osteopenia: a new indication for surgery in primary hyperparathyroidism","volume":"81","author":"Silverberg","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.otc.2004.02.004_BIB32","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1001\/archsurg.1992.01420100015003","article-title":"Normocalcemic hyperparathyroidism. Biochemical and symptom profiles before and after surgery","volume":"127","author":"Siperstein","year":"1992","journal-title":"Arch Surg"},{"key":"10.1016\/j.otc.2004.02.004_BIB33","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1359\/jbmr.2001.16.4.605","article-title":"Development of a novel immunoradiometric assay exclusively for biologically active whole parathyroid hormone 1\u201384: implications for improvement of accurate assessment of parathyroid function","volume":"16","author":"Gao","year":"2001","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.otc.2004.02.004_BIB34","doi-asserted-by":"crossref","first-page":"5353","DOI":"10.1210\/jc.2002-021370","article-title":"Summary statement from a workshop on asymptomatic primary hyperparathyroidism: a perspective for the 21st century","volume":"87","author":"Bilezikian","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.otc.2004.02.004_BIB35","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1097\/00000658-200205000-00008","article-title":"Six hundred fifty-six consecutive explorations for primary hyperparathyroidism","volume":"235","author":"Udelsman","year":"2002","journal-title":"Ann Surg"},{"key":"10.1016\/j.otc.2004.02.004_BIB36","doi-asserted-by":"crossref","first-page":"5658","DOI":"10.1210\/jc.86.12.5658","article-title":"Guidelines for diagnosis and therapy of MEN type 1 and type 2","volume":"86","author":"Brandi","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.otc.2004.02.004_BIB37","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/S0002-9343(97)00053-3","article-title":"Optimal dietary calcium intake in primary hyperparathyroidism","volume":"102","author":"Locker","year":"1997","journal-title":"Am J Med"},{"key":"10.1016\/j.otc.2004.02.004_BIB38","doi-asserted-by":"crossref","first-page":"337","DOI":"10.7326\/0003-4819-118-5-199303010-00003","article-title":"Estrogen protection against bone resorbing effects of parathyroid hormone infusion. Assessment by use of biochemical markers","volume":"118","author":"Cosman","year":"1993","journal-title":"Ann Intern Med"},{"issue":"Suppl 2","key":"10.1016\/j.otc.2004.02.004_BIB39","first-page":"N146","article-title":"The role of estrogens and related compounds in the management of primary hyperparathyroidism","volume":"17","author":"Marcus","year":"2002","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.otc.2004.02.004_BIB40","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1210\/jc.2002-020667","article-title":"Raloxifene lowers serum calcium and markers of bone turnover in postmenopausal women with primary hyperparathyroidism","volume":"88","author":"Rubin","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.otc.2004.02.004_BIB41","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1359\/jbmr.2001.16.1.113","article-title":"Effects of oral alendronate in elderly patients with osteoporosis and mild primary hyperparathyroidism","volume":"16","author":"Rossini","year":"2001","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.otc.2004.02.004_BIB42","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1210\/jc.2002-020890","article-title":"Oral alendronate increases bone mineral density in postmenopausal women with primary hyperparathyroidism","volume":"88","author":"Chow","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.otc.2004.02.004_BIB43","doi-asserted-by":"crossref","first-page":"4482","DOI":"10.1210\/jc.2001-010385","article-title":"Alendronate in the treatment of primary hyperparathyroid-related osteoporosis: a 2-year study","volume":"87","author":"Parker","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.otc.2004.02.004_BIB44","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1046\/j.1523-1755.61.s80.25.x","article-title":"The calcimimetic agents: perspectives for treatment","volume":"80","author":"Frazao","year":"2002","journal-title":"Kidney Int Suppl"},{"issue":"Suppl 2","key":"10.1016\/j.otc.2004.02.004_BIB45","first-page":"N141","article-title":"Calcimimetics in the treatment of primary hyperparathyroidism","volume":"17","author":"Antoniucci","year":"2002","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.otc.2004.02.004_BIB46","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1681\/ASN.V1261242","article-title":"Parathyroidectomy in patients on renal replacement therapy: an epidemiologic study","volume":"12","author":"Malberti","year":"2001","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.otc.2004.02.004_BIB47","doi-asserted-by":"crossref","first-page":"3801","DOI":"10.1210\/jc.86.8.3801","article-title":"Secondary hyperparathyroidism and bone turnover in elderly blacks and whites","volume":"86","author":"Harris","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.otc.2004.02.004_BIB48","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1056\/NEJM199803193381201","article-title":"Hypovitaminosis D in medical inpatients","volume":"338","author":"Thomas","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.otc.2004.02.004_BIB49","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1053\/ajkd.2001.28113","article-title":"Secondary hyperparathyroidism in chronic renal failure: pathogenic and clinical aspects","volume":"38","author":"Llach","year":"2001","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.otc.2004.02.004_BIB50","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1038\/ki.1997.41","article-title":"Depressed expression of calcium receptor in parathyroid gland tissue of patients with hyperparathyroidism","volume":"51","author":"Gogusev","year":"1997","journal-title":"Kidney Int"},{"key":"10.1016\/j.otc.2004.02.004_BIB51","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1038\/ki.1996.483","article-title":"Non-suppressible parathyroid hormone secretion is related to gland size in uremic secondary hyperparathyroidism","volume":"50","author":"Indridason","year":"1996","journal-title":"Kidney Int"},{"key":"10.1016\/j.otc.2004.02.004_BIB52","first-page":"358","article-title":"The parathyroid glands in chronic renal failure: a study of their growth and other properties made on the basis of findings in patients with hypercalcemia","volume":"114","author":"Lloyd","year":"1989","journal-title":"J Lab Clin Med"},{"key":"10.1016\/j.otc.2004.02.004_BIB53","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1056\/NEJM200005183422003","article-title":"Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis","volume":"342","author":"Goodman","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.otc.2004.02.004_BIB54","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1046\/j.1523-1755.2003.00878.x","article-title":"Paricalcitol versus calcitriol in the treatment of secondary hyperparathyroidism","volume":"63","author":"Sprague","year":"2003","journal-title":"Kidney Int"},{"key":"10.1016\/j.otc.2004.02.004_BIB55","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1056\/NEJMoa022536","article-title":"Survival of patients undergoing hemodialysis with paricalcitol or calcitriol therapy","volume":"349","author":"Teng","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.otc.2004.02.004_BIB56","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1097\/01.ASN.0000050224.03126.AD","article-title":"The calcimimetic AMG 073 as a potential treatment for secondary hyperparathyroidism of end-stage renal disease","volume":"14","author":"Quarles","year":"2003","journal-title":"J Am Soc Nephrol"},{"issue":"Suppl 3","key":"10.1016\/j.otc.2004.02.004_BIB57","first-page":"iii","article-title":"Guidelines for percutaneous ethanol injection therapy of the parathyroid glands in chronic dialysis patients","volume":"18","author":"Fukagawa","year":"2003","journal-title":"Nephrol Dial Transplant"}],"container-title":["Otolaryngologic Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0030666504000428?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0030666504000428?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,7,9]],"date-time":"2021-07-09T00:23:12Z","timestamp":1625790192000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0030666504000428"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,8]]},"references-count":57,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2004,8]]}},"alternative-id":["S0030666504000428"],"URL":"https:\/\/doi.org\/10.1016\/j.otc.2004.02.004","relation":{},"ISSN":["0030-6665"],"issn-type":[{"value":"0030-6665","type":"print"}],"subject":[],"published":{"date-parts":[[2004,8]]}}}